Twenty-six organizations, including the AHA, today urged congressional leaders to enact the Saving Access to Laboratory Services Act (H.R.8188, S.4499), bipartisan legislation that would update Medicare’s payment system for clinical diagnostic lab services and reporting requirements for labs. The Protecting Access to Medicare Act of 2014 reformed the Medicare Clinical Laboratory Fee Schedule to a single national fee schedule based on private market data from laboratories that service Medicare beneficiaries, but significant under sampling led to nearly $4 billion in cuts to hospital, physician and other labs providing commonly ordered tests for Medicare beneficiaries. Without a solution to this problem, labs face another round of cuts of up to 15% in January, at a time when they “remain at the forefront of patient care and responding to public health disruptions and threats such as COVID-19,” the groups wrote.

Related News Articles

Headline
In a letter submitted July 2 to the Centers for Medicare & Medicaid Services on guidance for the Medicare Drug Price Negotiation Program, the AHA expressed…
Headline
The Centers for Medicare & Medicaid Services June 28 released a proposed rule on mitigating the impact of significant, anomalous and highly suspect (SAHS)…
Headline
The Department of Health and Human Services June 26 announced beneficiary coinsurance reductions for 64 prescription drugs available through Medicare Part B.…
Perspective
For too long and for too many patients, the process of obtaining prior authorization for a medical procedure or medicine has been a tangled web, as people are…
Headline
The AHA June 14 sent a letter to the Senate Finance Committee, responding to questions included in a white paper the committee wrote on chronic care through…
Headline
The Centers for Medicare & Medicaid Services estimates national health spending grew 7.5% in 2023, reflecting increases in insurance growth, the agency…